Laird-Offringa IA - Search Results

1

Low level anti-Hu reactivity: A risk marker for small cell lung cancer?

Tsou JA, Kazarian M, Patel A, Galler JS, Laird-Offringa IA, Carpenter CL, London SJ. Tsou JA, et al. Cancer Detect Prev. 2009;32(4):292-9. doi: 10.1016/j.cdp.2008.06.006. Epub 2008 Dec 12. Cancer Detect Prev. 2009. PMID: 19070439 Free PMC article.

2

Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer.

Anglim PP, Galler JS, Koss MN, Hagen JA, Turla S, Campan M, Weisenberger DJ, Laird PW, Siegmund KD, Laird-Offringa IA. Anglim PP, et al. Mol Cancer. 2008 Jul 10;7:62. doi: 10.1186/1476-4598-7-62. Mol Cancer. 2008. PMID: 18616821 Free PMC article.

3

Immune response in lung cancer mouse model mimics human anti-Hu reactivity.

Kazarian M, Calbo J, Proost N, Carpenter CL, Berns A, Laird-Offringa IA. Kazarian M, et al. J Neuroimmunol. 2009 Dec 10;217(1-2):38-45. doi: 10.1016/j.jneuroim.2009.08.014. Epub 2009 Sep 17. J Neuroimmunol. 2009. PMID: 19765830 Free PMC article.

4

Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Kazarian M, Laird-Offringa IA. Kazarian M, et al. Mol Cancer. 2011 Mar 30;10:33. doi: 10.1186/1476-4598-10-33. Mol Cancer. 2011. PMID: 21450098 Free PMC article. Review.

5

DNA methylation analysis: a powerful new tool for lung cancer diagnosis.

Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. Tsou JA, et al. Oncogene. 2002 Aug 12;21(35):5450-61. doi: 10.1038/sj.onc.1205605. Oncogene. 2002. PMID: 12154407 Review.

6

Classification of individual lung cancer cell lines based on DNA methylation markers: use of linear discriminant analysis and artificial neural networks.

Marchevsky AM, Tsou JA, Laird-Offringa IA. Marchevsky AM, et al. J Mol Diagn. 2004 Feb;6(1):28-36. doi: 10.1016/S1525-1578(10)60488-6. J Mol Diagn. 2004. PMID: 14736824 Free PMC article.

7

Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.

Tsou JA, Shen LY, Siegmund KD, Long TI, Laird PW, Seneviratne CK, Koss MN, Pass HI, Hagen JA, Laird-Offringa IA. Tsou JA, et al. Lung Cancer. 2005 Feb;47(2):193-204. doi: 10.1016/j.lungcan.2004.08.003. Lung Cancer. 2005. PMID: 15639718

8

DNA methylation profile of 28 potential marker loci in malignant mesothelioma.

Tsou JA, Galler JS, Wali A, Ye W, Siegmund KD, Groshen S, Laird PW, Turla S, Koss MN, Pass HI, Laird-Offringa IA. Tsou JA, et al. Lung Cancer. 2007 Nov;58(2):220-30. doi: 10.1016/j.lungcan.2007.06.015. Epub 2007 Jul 30. Lung Cancer. 2007. PMID: 17659810 Free PMC article.

9

Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.

Tsou JA, Galler JS, Siegmund KD, Laird PW, Turla S, Cozen W, Hagen JA, Koss MN, Laird-Offringa IA. Tsou JA, et al. Mol Cancer. 2007 Oct 29;6:70. doi: 10.1186/1476-4598-6-70. Mol Cancer. 2007. PMID: 17967182 Free PMC article.

10

Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.

Pulido MA, DerHartunian MK, Qin Z, Chung EM, Kang DS, Woodham AW, Tsou JA, Klooster R, Akbari O, Wang L, Kast WM, Liu SV, Verschuuren JJGM, Aswad DW, Laird-Offringa IA. Pulido MA, et al. Among authors: laird offringa ia. J Neuroimmunol. 2016 Oct 15;299:70-78. doi: 10.1016/j.jneuroim.2016.09.002. Epub 2016 Sep 3. J Neuroimmunol. 2016. PMID: 27725125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters